siRNA loaded dendritic cell vaccine (Alnylam Pharmaceuticals)

N/A

Report date: 2026/01/26 17:59:08

Base Information

Drug NamesiRNA loaded dendritic cell vaccine (Alnylam Pharmaceuticals)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccineVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionProgrammed death-ligand 2 modulatorsProgrammed death-ligand 1 modulators

TargetsProgrammed death-ligand 1Programmed death-ligand 2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAlnylam Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAlnylam Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A